Third Point Addresses Sotheby's Adoption of a Poison Pill - A Relic from the 1980's
Third Point Addresses Sotheby's Adoption of a Poison Pill - A Relic from the 1980's
NEW YORK--(BUSINESS WIRE)-- Third Point is disappointed that Sotheby's (NYS: BID) Board of Directors has trotted out the poison pill - a relic from the 1980's - as its disproportionate response to the valid concerns expressed in our October 2nd letter. Rather than address our well-documented citations of mismanagement and initiate a constructive dialogue with its largest shareholder, the Board and the CEO have attempted to further entrench themselves.
Third Point's involvement does not pose a threat to either the Company or our fellow shareholders, all of whom will benefit from our considerable efforts. It is clear that today, the Chief Executive Officer and his hand-picked directors have put their job security ahead of shareholders.
Given their personal interests and miniscule shareholdings of Sotheby's, the Board's actions - disenfranchising its owners who may wish to acquire a more significant stake - come as no surprise. We hope this will be the Ruprecht Board's final snub to its shareholders. It would be unfortunate if they instead refuse to undertake a fresh start until one is imposed upon them during proxy season.
About Third Point LLC: Third Point LLC is an SEC-registered investment adviser headquartered in New York. Third Point is Sotheby's largest shareholder with a 9.3% stake in the Company's outstanding shares. Founded in 1995, Third Point follows an event-driven approach to investing globally. Third Point manages assets for Third Point Reinsurance Limited (NYS: TPRE) and Third Point Offshore Investors Limited (LSE:TPOU LN), as well as its private funds.
Third Point LLC
Elissa Doyle, 212-715-4907
Managing Director
edoyle@thirdpoint.com
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS:
The article Third Point Addresses Sotheby's Adoption of a Poison Pill - A Relic from the 1980's originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
